APA (7th ed.) Citation

Serebrova, S. Y., Evteev, V. V., Demchenkova, E. Y., Zhuravleva, M. V., & Prokofiev, A. B. (2024). Current Mesalazine Products: Differences in Enteric-Coated Dosage Forms and Pharmaceutical Risks of Clinical Efficacy Reduction (Review). Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products».

Chicago Style (17th ed.) Citation

Serebrova, S. Yu., V. V. Evteev, E. Yu Demchenkova, M. V. Zhuravleva, and A. B. Prokofiev. Current Mesalazine Products: Differences in Enteric-Coated Dosage Forms and Pharmaceutical Risks of Clinical Efficacy Reduction (Review). Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», 2024.

MLA (9th ed.) Citation

Serebrova, S. Yu., et al. Current Mesalazine Products: Differences in Enteric-Coated Dosage Forms and Pharmaceutical Risks of Clinical Efficacy Reduction (Review). Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», 2024.